Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 24, 2015

Cardiovascular Effects of Biguanides vs Sulfonylureas

BMC Endocrine Disorders


Additional Info

Disclosure statements are available on the authors' profiles:

BMC Endocrine Disorders
Reduced Vascular Events in Type 2 Diabetes by Biguanide Relative to Sulfonylurea: Study in a Japanese Hospital Database
BMC Endocr Disord 2015 Sep 01;15(1)49, M Tanabe, T Nomiyama, R Motonaga, K Murase, T Yanase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading